Bring to life Merck’s media strategy, showcasing the company as the premier research-intensive biopharmaceutical company in the world.• Lead company’s financial communications / media across quarterly earnings, annual shareholder meeting, and financial events such as J.P. Morgan, among other initiatives.• Foster relationships with top-tier reporters and editors to protect, defend and enhance company’s reputation. Outlets include The Wall Street Journal, New York Times, CNBC, Reuters, Bloomberg, Financial Times, Barron’s, Forbes, Fox Business, Yahoo Finance, Good Morning America and Endpoints, among others.• Partner internally with stakeholders across geographies and business areas to create storytelling strategies that showcase our Company’s business developments, research, innovation, collaborations, and other milestones.• Create and maintain media response plan, including proactively planning for and managing issues affecting company and industry. Serve as company spokesperson.• Prepare and counsel Executive Team members and other senior leaders for media interviews and speaking engagements.

In addition to Director, Global Oncology Communications responsibilities, led executive communications initiatives for $40B+ Human Health division, ensuring engagement across 75+ markets and 18,000 employees. Advised and supported three Executive Team members, including chief marketing officer. Human Health portfolio and pipeline spans oncology, vaccines, cardiometabolic, infectious diseases, immunology, neuroscience, hospital acute care, and PAH.

Led communications (internal / external) for $16B US Oncology team and provided communications counsel to president, US Oncology. Member of US Oncology Leadership Team (USOLT). • Navigated period of organizational change and COVID to support business transformation from $500M to $11B, driving culture of trust and 92% employee engagement.• Developed integrated communications strategies including thought leadership, traditional media, digital, internal and social channels to engage internal and external stakeholders.• Executed global external product communications for oncology products around key regulatory milestones, such as KEYNOTE-158 (endometrial cancer) and KEYNOTE-394 (hepatocellular carcinoma).• Led external oncology communications for Latin America (LATAM) region. Point for commercial team to understand priorities and identify opportunities for driving impactful stories in LATAM countries.

A membership community for communications leaders.

Leading northeast paper distributor with 16,000 products and a world-class printing operation that generates millions of impressions per day. • Drove 790% sales growth into healthcare and educational sectors through communications and sales initiatives.

($17B global medical device leader; 46,000 employees worldwide)Promoted and sold surgical lights, booms, OR tables, video, EMR integration and HoloLens 3D room design to hospitals and surgery centers. • Grew Northern PA expansion territory from $342K to $1.6M (366%). • Quota Achiever; #4 out of 92 reps (annual territory growth). • Educated surgeons and nurses on proper use and maintenance of Stryker products; developed new toolkit for using PR to drive sales.

($7B global medical device leader; 32,000 employees worldwide) Led the corporate communications, corporate citizenship, external and internal communications across North and South America. • Served as a company spokesperson. Averted negative publicity of 30+ potential crises.• Developed external communications plan across 7 divisions & drove largest 4-year increase of earned media in company history: GI, urology, respiratory, minimally invasive surgery, ENT, surgical energy, GYN.• Generated largest 4-year increase of earned media in company history and 96% employee satisfaction with internal communications.• Oversaw company boilerplates, corporate & product press releases, executive PPTs, broadcasts, town halls and patient speaker series that drove 96% employee satisfaction.

(Boutique agency specializing in communication and marketing strategies for healthcare and technology companies)Worked directly with C-level client decision makers in development and execution of communications and marketing strategies. Managed four direct reports.• Led business communications for launch of industry’s 1st rapid OTC HIV test and rapid Hepatitis C test, generating 2+ billion impressions and driving company stock price to 10-year high.• Partnered with senators, congressman, mayors, celebrities, athletes, pastors, and advocacy groups to promote rapid HIV and Hep C testing. Results included 18+ events, 2 billion earned media impressions, 125+ nationally televised segments, and 125,000+ people tested. • Led media relations for ClearCount's surgical sponge RFID tracking system, securing #1 small business story for 88 days on Time.com.

Promoted to take on management of marketing, PR, creative and website development engagements for life sciences companies. Served as key point of contact to client companies.• Placed clients in 137 top-tier national print and broadcast media companies such as WSJ, NYT, USA Today, Time, Wired, Forbes, CNBC Squawk and Fox Business.• Created annual Mayors' Campaign Against HIV and NASDAQ opening bell ceremony for OraSure in support of National HIV Testing Day and World AIDS Day.• Championed “Step Up to the Plate Against Hep C” campaign, enabling 23,000 people to be tested at MLB ball parks, in partnership with Merck, OraSure, MLB celebrities and American Liver Foundation.

Managed PR, survey projects, HTML email campaigns, and creative projects for life sciences and technology clients.• Expanded client base by 4,031 members, boosted visibility with publication of 135 articles by launching 2.0 Social Network that facilitated research and collaboration in life sciences sector.• Generated 50% increase in site visits and 15% spike in new customer revenue by developing PR and digital campaign for GENCO Marketplace, a B2B wholesaler of surplus inventories.

Conducted market research analysis reports on emerging life science technologies and markets.